NR 508 Week 1 Quiz
NR 508 : ADVANCED PHARMACOLOGY
, NR 508 Week 1 Quiz
1. Question : Osteopenia is diagnosed in a 55-year-old woman who has not had a
period in 15 months. She has a positive family history of breast
cancer. The primary care NP should recommend:
Student
Answer: testosterone therapy.
estrogen-only therapy.
nonhormonal drugs for osteoporosis.
estrogen-progesterone therapy for 1 to 2 years.
Instructor Although estrogen slows the progression of osteoporosis, it also increases the
Explanation: risk of breast cancer when initiated early in menopause. This woman should
receive a nonhormonal treatment for osteoporosis and may receive HT in 5
years if menopausal symptoms persist. Testosterone therapy, estrogen-only
therapy, and estrogen-progesterone therapy are not indicated.
Points Received: 2 of 2
Comments:
Question 2 Question : A patient takes a cardiac medication that has a very narrow
. therapeutic range. The primary care NP learns that the particular
brand the patient is taking is no longer covered by the patient’s
medical plan. The NP knows that the bioavailability of the drug varies
from brand to brand. The NP should:
Student Answer:
contact the insurance provider to explain why this particular
formulation is necessary.
change the patient’s medication to a different drug class that
doesn’t have these bioavailability variations.
accept the situation and monitor the patient closely for drug
effects with each prescription refill.
ask the pharmaceutical company that makes the drug for
samples so that the patient does not incur out-of-pocket expense.
Instructor In this case, the NP should advocate for the desired drug because
Explanation: changing the drug can have life-threatening consequences. If this fails,
other options may have to be explored.
Points Received: 2 of 2
Comments:
NR 508 : ADVANCED PHARMACOLOGY
, NR 508 Week 1 Quiz
1. Question : Osteopenia is diagnosed in a 55-year-old woman who has not had a
period in 15 months. She has a positive family history of breast
cancer. The primary care NP should recommend:
Student
Answer: testosterone therapy.
estrogen-only therapy.
nonhormonal drugs for osteoporosis.
estrogen-progesterone therapy for 1 to 2 years.
Instructor Although estrogen slows the progression of osteoporosis, it also increases the
Explanation: risk of breast cancer when initiated early in menopause. This woman should
receive a nonhormonal treatment for osteoporosis and may receive HT in 5
years if menopausal symptoms persist. Testosterone therapy, estrogen-only
therapy, and estrogen-progesterone therapy are not indicated.
Points Received: 2 of 2
Comments:
Question 2 Question : A patient takes a cardiac medication that has a very narrow
. therapeutic range. The primary care NP learns that the particular
brand the patient is taking is no longer covered by the patient’s
medical plan. The NP knows that the bioavailability of the drug varies
from brand to brand. The NP should:
Student Answer:
contact the insurance provider to explain why this particular
formulation is necessary.
change the patient’s medication to a different drug class that
doesn’t have these bioavailability variations.
accept the situation and monitor the patient closely for drug
effects with each prescription refill.
ask the pharmaceutical company that makes the drug for
samples so that the patient does not incur out-of-pocket expense.
Instructor In this case, the NP should advocate for the desired drug because
Explanation: changing the drug can have life-threatening consequences. If this fails,
other options may have to be explored.
Points Received: 2 of 2
Comments:
